CGEM Cullinan Management, Inc.

Cullinan Management is advancing a growing portfolio of innovative, early-stage clinical therapeutic assets by capitalizing on the latest scientific breakthroughs. We combine a unique portfolio model with innovative sourcing techniques and drug development expertise to discover and advance candidates for potentially transformative oncology drugs.

$24.96  -1.07 (-4.11%)
As of 06/22/2021 15:59:41 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/13/2009
Outstanding shares:  43,516,125
Average volume:  310,082
Market cap:   $1,107,050,220
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    230031106
ISIN:        US2300311063
Sedol:      BM90J52
Valuation   (See tab for details)
PE ratio:   -16,187.81
PB ratio:   2.43
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy